Carisma Therapeutics Inc.

Please note: The information displayed on this page might be outdated.
Carisma Therapeutics Inc.: - CARISMA Therapeutics Inc. is a clinical stage biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.
Based in...
US - Middle Atlantic
Clinical Stage
Phase l or ll
Disease Space
3675 Market Street
Philadelphia, PA 19104
United States

Company Participants at Fall Private Company Showcase 2020

Steven Kelly
Carisma Therapeutics Inc., CEO
Steven Kelly joined Carisma Therapeutics in February 2018 bringing nearly thirty years of experience in Pharma/Biotech at all phases of the business across multiple therapeutic categories. Prior to joining Carisma, Mr. Kelly held a number of leadership positions in the biotechnology industry including: CEO, Pinteon Therapeutics; CEO, Theracrine; CCO, BioVex; CEO, Innovive Pharmaceuticals; as well as various commercial and manufacturing roles at Sanofi, IDEC Pharmaceuticals and Amgen. Steve holds a BS from the University of Oregon and an MBA from Cornell University.

Upcoming Company Event Participation